1. The above statement of financial result were reviewed by audit committee and approved by the board of directors at their meeting held on May 30, 2011.
2. The company is engaged in manufacture of Drugs, Pharmaceuticals & Chemicals as such there are no separate reportable segment as per accounting standard 17.
3. The figures have been regrouped wherever necessary.
4. During the quarter company has reissued 5712500 forfeited equity shares @ Rs. 7 each after obtaining the approval from Members
Ramesh Shah
Chairman cum Managing Director